you are here: Home News Cadila Healthcare

Cadila Healthcare

Zydus Lifesciences jumps over 5% after US arm buys global rights for BridgeBio's Nulibry
Accumulate Cadila Healthcare; target of Rs 445: KR Choksey
Buy Cadila Healthcare; target of Rs 560: Sharekhan
Buy Cadila Healthcare; target of Rs 490: Motilal Oswal
Cadila Health Consolidated December 2021 Net Sales at Rs 3,655.00 crore, down 3.7% Y-o-Y
Cadila Health Standalone December 2021 Net Sales at Rs 1,830.30 crore, down 4.61% Y-o-Y
Hot Stocks | Here's why you should buy Maruti Suzuki, Cadila Healthcare for short term
Cadila re-appoints Sharvil P Patel as MD for another five-year term
Cadila Healthcare Q3 PAT seen up 3.2% YoY to Rs 544 cr: Prabhudas Lilladher
Buy Cadila Healthcare: target of Rs 720: Sharekhan
Cadila Health Standalone September 2021 Net Sales at Rs 2,008.90 crore, down 2.33% Y-o-Y
Cadila Healthcare Q2 PAT seen up 19% YoY to Rs 563.3 cr: Prabhudas Lilladher
Cadila Healthcare enters pact with Shilpa Medicare for production of ZyCoV-D vaccine
Cadila Healthcare share price falls on sale of two brands
Cadila Healthcare unit inks pact to sell two brands to Integrace
Buy Cadila Healthcare target of Rs 695: Prabhudas Lilladher
Buy Cadila Healthcare; target of Rs 720: Sharekhan
Cadila: Vaccine opportunity unfolds
Cadila Healthcare share price rises 7% after DCGI approves ZyCoV-D COVID vaccine
Buy Cadila Healthcare; target of Rs 670: Motilal Oswal
What should investors do with Cadila Healthcare after Q1 earnings: buy, sell or hold?
Cadila Health Consolidated June 2021 Net Sales at Rs 4,025.40 crore, up 10.59% Y-o-Y
Cadila Health Standalone June 2021 Net Sales at Rs 2,123.40 crore, up 18.24% Y-o-Y
Cadila Healthcare arm completes sale of animal health business for Rs 2,921 crore
Cadila Healthcare Q1 PAT seen up 63.9% YoY to Rs 744 cr: KRChoksey

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Cadila Healthcare

Zydus Lifesciences jumps over 5% after US arm buys global rights for BridgeBio's Nulibry

Accumulate Cadila Healthcare; target of Rs 445: KR Choksey

Buy Cadila Healthcare; target of Rs 560: Sharekhan

Buy Cadila Healthcare; target of Rs 490: Motilal Oswal

Cadila Health Consolidated December 2021 Net Sales at Rs 3,655.00 crore, down 3.7% Y-o-Y

Cadila Health Standalone December 2021 Net Sales at Rs 1,830.30 crore, down 4.61% Y-o-Y

Hot Stocks | Here's why you should buy Maruti Suzuki, Cadila Healthcare for short term

Cadila re-appoints Sharvil P Patel as MD for another five-year term

Cadila Healthcare Q3 PAT seen up 3.2% YoY to Rs 544 cr: Prabhudas Lilladher

Buy Cadila Healthcare: target of Rs 720: Sharekhan

Cadila Health Standalone September 2021 Net Sales at Rs 2,008.90 crore, down 2.33% Y-o-Y

Cadila Healthcare Q2 PAT seen up 19% YoY to Rs 563.3 cr: Prabhudas Lilladher

Cadila Healthcare enters pact with Shilpa Medicare for production of ZyCoV-D vaccine

Cadila Healthcare share price falls on sale of two brands

Cadila Healthcare unit inks pact to sell two brands to Integrace

Buy Cadila Healthcare target of Rs 695: Prabhudas Lilladher

Buy Cadila Healthcare; target of Rs 720: Sharekhan

Cadila: Vaccine opportunity unfolds

Cadila Healthcare share price rises 7% after DCGI approves ZyCoV-D COVID vaccine

Buy Cadila Healthcare; target of Rs 670: Motilal Oswal

What should investors do with Cadila Healthcare after Q1 earnings: buy, sell or hold?

Cadila Health Consolidated June 2021 Net Sales at Rs 4,025.40 crore, up 10.59% Y-o-Y

Cadila Health Standalone June 2021 Net Sales at Rs 2,123.40 crore, up 18.24% Y-o-Y

Cadila Healthcare arm completes sale of animal health business for Rs 2,921 crore

Cadila Healthcare Q1 PAT seen up 63.9% YoY to Rs 744 cr: KRChoksey